ATLAS / Macro Radar / Reporting / BCRX

BIOCRYST PHARMACEUTICALS INC (BCRX) reporting calendar

BIOCRYST PHARMACEUTICALS INC files periodic reports with the SEC as BCRX on Nasdaq. Atlas tracks 42 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
25 Jul 2026 – 16 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
6 May 2026
Reports on record
42

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 36 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open BCRX market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20266 May 202636 days0001628280-26-031238
10-K31 Dec 202526 Feb 202657 days0001628280-26-012240
10-Q30 Sep 20254 Nov 202535 days0001628280-25-048785
10-Q30 Jun 20255 Aug 202536 days0001628280-25-037795
10-Q31 Mar 20256 May 202536 days0001628280-25-022658
10-K31 Dec 202425 Feb 202556 days0001628280-25-007715
10-Q30 Sep 20245 Nov 202436 days0001628280-24-045364
10-Q30 Jun 20246 Aug 202437 days0001628280-24-035170
10-Q31 Mar 20247 May 202437 days0001628280-24-021069
10-K31 Dec 202327 Feb 202458 days0001628280-24-007205
10-Q30 Sep 20238 Nov 202339 days0001628280-23-037847
10-Q30 Jun 20237 Aug 202338 days0001628280-23-027820
10-Q31 Mar 20238 May 202338 days0001628280-23-016458
10-K31 Dec 202227 Feb 202358 days0001628280-23-005259
10-Q30 Sep 20224 Nov 202235 days0001628280-22-028463
10-Q30 Jun 20225 Aug 202236 days0001628280-22-021373
10-Q31 Mar 20229 May 202239 days0001171843-22-003423
10-K31 Dec 202128 Feb 202259 days0001171843-22-001460
10-Q30 Sep 20214 Nov 202135 days0001171843-21-007570
10-Q30 Jun 20219 Aug 202140 days0001171843-21-005674
10-Q31 Mar 20217 May 202137 days0001171843-21-003310
10-K31 Dec 20201 Mar 202160 days0001171843-21-001411
10-Q30 Sep 20206 Nov 202037 days0001171843-20-007740
10-Q30 Jun 20207 Aug 202038 days0001171843-20-005753
10-Q31 Mar 202011 May 202041 days0001171843-20-003557
10-K31 Dec 201913 Mar 202073 days0001171843-20-001710
10-Q30 Sep 20198 Nov 201939 days0001171843-19-007384
10-Q30 Jun 20198 Aug 201939 days0001171843-19-005326
10-Q31 Mar 20199 May 201939 days0001171843-19-003220
10-K31 Dec 201814 Mar 201973 days0001171843-19-001727
10-Q30 Sep 20188 Nov 201839 days0001171843-18-007788
10-Q30 Jun 20189 Aug 201840 days0001171843-18-005928
10-Q31 Mar 20189 May 201839 days0001171843-18-003719
10-K31 Dec 201712 Mar 201871 days0001171843-18-001855
10-Q30 Sep 20178 Nov 201739 days0001171843-17-006746
10-Q30 Jun 20178 Aug 201739 days0001171843-17-004830
10-Q31 Mar 20178 May 201738 days0001171843-17-002784
10-K31 Dec 201627 Feb 201758 days0001171843-17-001159
10-Q30 Sep 20168 Nov 201639 days0001171843-16-013033
10-Q30 Jun 20168 Aug 201639 days0001171843-16-011576

Source: SEC EDGAR company submissions for CIK 0000882796. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.